Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Oscar Health, Inc.OSCR · Entity 3582 | EVP & Chief Legal Officer | December 01, 2024 | December 03, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Oscar Health, Inc.
Report date December 01, 2024 · Filed December 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 241,488 |
Ending reported balance
After 2024-12-02 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2024-12-01 · Exercise / conversion · Acquired 20,424 · Balance 239,331 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 2 · 2024-12-01 · Exercise / conversion · Acquired 16,447 · Balance 255,778 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 3 · 2024-12-01 · Exercise / conversion · Acquired 4,867 · Balance 260,645 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 4 · 2024-12-02 · Sale · Disposed 18,812 · Balance 241,833 F2: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.46 to $18.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Row 5 · 2024-12-02 · Sale · Disposed 345 · Balance 241,488 F2: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.46 to $18.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 102,125 |
Reported balance
After 2024-12-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-12-01 · Exercise / conversion · Disposed 20,424 · Balance 102,125 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F5: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2022. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 148,027 |
Reported balance
After 2024-12-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-12-01 · Exercise / conversion · Disposed 16,447 · Balance 148,027 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F6: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 43,803 |
Reported balance
After 2024-12-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2024-12-01 · Exercise / conversion · Disposed 4,867 · Balance 43,803 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F7: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.46 to $18.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.46 to $18.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F5: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2022.
F6: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023.
F7: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2023 Filed Mar 3, 2023 21:12 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 7,252 | $4.75 | $34,450.63 |
DisclosureSEC source: 0001562180-23-002354 · primarydocument.xml · nonDerivative · entry 2 Bopitiya Ranmali · CIK 0001908069 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,038 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:12 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 20,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-002354 · primarydocument.xml · derivative · entry 3 Bopitiya Ranmali · CIK 0001908069 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,098 Underlying: Class A Common Stock · 20,425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2022. F3 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2022. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:12 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 20,425 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-002354 · primarydocument.xml · nonDerivative · entry 1 Bopitiya Ranmali · CIK 0001908069 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 21:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 6,281 | $2.84 | $17,812.92 |
DisclosureSEC source: 0001562180-22-008041 · primarydocument.xml · nonDerivative · entry 2 Bopitiya Ranmali · CIK 0001908069 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,865 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.905 to $2.790, inclusive.The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 20,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-008041 · primarydocument.xml · derivative · entry 3 Bopitiya Ranmali · CIK 0001908069 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,523 Underlying: Class A Common Stock · 20,425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2022. F4 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2022. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 20,425 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-008041 · primarydocument.xml · nonDerivative · entry 1 Bopitiya Ranmali · CIK 0001908069 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 02, 2022 Filed Sep 6, 2022 20:19 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 6,167 | $5.85 | $36,076.95 |
DisclosureSEC source: 0001562180-22-006510 · primarydocument.xml · nonDerivative · entry 2 Bopitiya Ranmali · CIK 0001908069 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,721 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:19 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 20,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-006510 · primarydocument.xml · derivative · entry 3 Bopitiya Ranmali · CIK 0001908069 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,948 Underlying: Class A Common Stock · 20,425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2022. F3 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2022. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:19 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 20,425 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-006510 · primarydocument.xml · nonDerivative · entry 1 Bopitiya Ranmali · CIK 0001908069 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 20:09 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 5,961 | $4.69 | $27,938.01 |
DisclosureSEC source: 0001562180-22-004764 · primarydocument.xml · nonDerivative · entry 2 Bopitiya Ranmali · CIK 0001908069 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,463 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.68 to $4.741, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:09 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 20,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004764 · primarydocument.xml · derivative · entry 3 Bopitiya Ranmali · CIK 0001908069 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,373 Underlying: Class A Common Stock · 20,424 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2022. F4 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:09 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 20,424 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-004764 · primarydocument.xml · nonDerivative · entry 1 Bopitiya Ranmali · CIK 0001908069 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.